Going to be interesting to see how this plays out, considering there always seems to be a shortage of staff in ALFs.
CORONA The Covid Vaccines and Side Effects thread (all things vaccine)
- Thread starter Melodi
- Start date
Going to be interesting to see how this plays out, considering there always seems to be a shortage of staff in ALFs.
Countrymouse
Country exile in the city
I was wondering about that this morning---
If HEALTH-CARE WORKERS are supposed to take it FIRST--but it makes them INCAPABLE OF WORKING for who knows HOW long---
What sort of health crisis will we have THEN?
Melodi
Disaster Cat
Well, we find out really fast what the actual rate of adverse reactions is, I guess.
I noticed that in the UK, they wanted to "target" care home patients and people in great old-age first, but then they realized they may first have to do the NHS staff workers (nurses, doctors, etc).
My first thought was "good luck keeping up with bad reactions from people in nursing homes, since proving any particular condition in people already ill as vaccine-related would be an uphill battle."
On the other hand, doing health care workers first makes perfect sense unless it is likely to render even more of them onto the "off-duty" list for few days to a week.
Melodi
Disaster Cat
OK Bloomberg is now reporting that hospitals are worried that enough staff may be impacted by "side effects" of the vaccine to cause staff shortages! They mention the same basic figures that Nightwolf came up with in his search of released information of about 10 to 15 percent of those taking the vaccine getting sick for at least a day or two, bad enough not to be able to work.
Notice how some hospitals plan to vaccinate their staff when "they have days off anyway" so you peasants er...a.. we mean highly trained and overworked medical staff, you can not only get sick for up to 48 hours but you can do it on your own days off - no need to pay for sick leave or anything.
Of course, it is being plugged as "preventing staff shortages" which it does that too - interesting they are worried about "health professionals panicking" scaring the public away from the vaccine.
Again, Nightwolf said he would take it if had to and he's let me take if mandated but not at the same time in case the other one need full-time care for a day or two, or worse had symptoms that indicated a need for observation in a hospital setting.
Melodi
Vaccines’ Side Effects Risk Sidelining Health Workers While Cases Surge
Angelica LaVito and Riley Griffin 13 hrs ago
http://a.msn.com/00/en-us/BB1bC0h8?ocid=sf
(Bloomberg) --
Covid-19 vaccine side-effects that range from fevers and chills to headaches and joint pain could keep some doctors and nurses from working amid a nationwide surge in hospitalizations.
Health systems are gearing up to vaccinate key hospital staff with the Pfizer Inc. and Moderna Inc. coronavirus shots, which could start shipping in the U.S. in a matter of weeks, pending emergency-use authorizations.
Earlier this week, federal advisers recommended U.S. health-care workers be immunized first, along with residents of long-term care facilities. For hospitals, that could pose significant scheduling issues at a time when many are filling up. More than 100,000 Americans were hospitalized with the virus on Wednesday, according to data from the Covid Tracking Project.
Providers will need to pull medical staff from the bedside to the vaccination clinic to get their shots. And if side effects do occur, they could lose key workers for a couple of days. To overcome this, some hospitals plan to stagger staff to keep units covered. Others are exploring giving workers the shots at the end of their shifts, before they have a few days off.
Still, it’s difficult to know what to expect without seeing full data from Pfizer and Moderna’s large, late-stage clinical trials, said Paul Biddinger, vice chair of emergency preparedness at Massachusetts General Hospital.
“It’s a little easier to create a model for how we should stagger employee vaccinations when we know how commonly [side effects] are occurring and with what severity,” Biddinger said. Plans could change when more robust data becomes available, he added.
Though the pharmaceutical companies have yet to release full results from their largest trials, disclosures from earlier tests in recent press releases give a sense of their safety profiles.
© Photographer: Go Nakamura/Bloomberg hospital texas
A medical staff member treats a patient at the Covid-19 Intensive Care Unit of a hospital in Houston, Texas on Nov. 8.
Photographer: Go Nakamura/Bloomberg
Pfizer and its German partner BioNTech SE said on Nov. 18 that no serious safety concerns were observed in their late-stage trial. Among participants who got the two-dose vaccine regimen, 3.8% experienced fatigue, and 2% had headaches. Older adults reported fewer and milder adverse events. In an earlier trial, the companies identified cases of mild-to-moderate fever.
Moderna, meanwhile, said on Nov. 16 that it had also identified no serious safety concerns in its late-stage trial. Mild-to-moderate side effects included fatigue (9.7%), muscle or joint pain (5.2%) headache (4.5%) and injection-site pain (2.7%). The side effects were more common after the second dose of the two-dose vaccine.
Gallery: 6 Things That Put You More at Risk for Coronavirus (ETNT Health)
“We have been very reassured that we have not seen cases of things we would not expect,” said Buddy Creech, the director of Vanderbilt Vaccine Research Program who is leading trials of Covid-19 vaccines. “We see side effect profiles that are common to other vaccines we use.”
Small Proportion
Only a small proportion of those who get coronavirus vaccines will confront side effects, according to Creech, who also serves as the principal investigator for both Moderna and Johnson & Johnson’s Phase 3 clinical trials.
Remember, “it’s not 100% of people who have fevers and chills,” Creech said Thursday during a media panel held by the Infectious Disease Society of America, of which he is a member.
However, the potential that there might be side-effects strong enough to put health workers out of commission needs to be raised before the vaccination campaign begins, Creech said.
Read More: Hospitals Race to Set Vaccine Priorities for Health-Care Workers
If the possibility isn’t effectively communicated, he added, hospitals might be left understaffed. At the same time, medical workers must also be taught to distinguish between side effects from the vaccine and symptoms from Covid-19, given they are highly exposed to the virus.
“We will need to be somewhat strategic about who is offered the vaccine, so we’re working with clinical leads in those areas to make sure they stagger out their health-care personnel,” said Jeanmarie Mayer, chief of infection prevention at University of Utah Health, said Thursday at a press conference.
End of Shift
Utah-based Intermountain Healthcare is one system that may vaccinate workers at the end of their shifts before they have a few days off, said Kristin Dascomb, the medical director of infection prevention and employee health.
“When you’re having your weekend off, you might have the opportunity to have the symptoms, as mild as they might be, so that you’re not taking time off away from work when we are stressing caregivers at this time,” Dascomb said at the news conference.
Hospitals are generally planning to prioritize staff who work directly with coronavirus patients since they are at the greatest risk of contracting the disease on the job.
Mass General’s Biddinger worries health-care workers who confront unexpected symptoms might panic and think the shots are faulty, sowing even more mistrust among an already skeptical public.
“We’re trying to be very honest about what people should expect when they get the vaccine, but to remind them that it’s a good thing and it actually means that vaccination is helping us get more immune,” he said.
For more articles like this, please visit us at bloomberg.com
Notice how some hospitals plan to vaccinate their staff when "they have days off anyway" so you peasants er...a.. we mean highly trained and overworked medical staff, you can not only get sick for up to 48 hours but you can do it on your own days off - no need to pay for sick leave or anything.
Of course, it is being plugged as "preventing staff shortages" which it does that too - interesting they are worried about "health professionals panicking" scaring the public away from the vaccine.
Again, Nightwolf said he would take it if had to and he's let me take if mandated but not at the same time in case the other one need full-time care for a day or two, or worse had symptoms that indicated a need for observation in a hospital setting.
Melodi
MSN
www.msn.com
Angelica LaVito and Riley Griffin 13 hrs ago
http://a.msn.com/00/en-us/BB1bC0h8?ocid=sf
(Bloomberg) --
Covid-19 vaccine side-effects that range from fevers and chills to headaches and joint pain could keep some doctors and nurses from working amid a nationwide surge in hospitalizations.
Health systems are gearing up to vaccinate key hospital staff with the Pfizer Inc. and Moderna Inc. coronavirus shots, which could start shipping in the U.S. in a matter of weeks, pending emergency-use authorizations.
Earlier this week, federal advisers recommended U.S. health-care workers be immunized first, along with residents of long-term care facilities. For hospitals, that could pose significant scheduling issues at a time when many are filling up. More than 100,000 Americans were hospitalized with the virus on Wednesday, according to data from the Covid Tracking Project.
Providers will need to pull medical staff from the bedside to the vaccination clinic to get their shots. And if side effects do occur, they could lose key workers for a couple of days. To overcome this, some hospitals plan to stagger staff to keep units covered. Others are exploring giving workers the shots at the end of their shifts, before they have a few days off.
Still, it’s difficult to know what to expect without seeing full data from Pfizer and Moderna’s large, late-stage clinical trials, said Paul Biddinger, vice chair of emergency preparedness at Massachusetts General Hospital.
“It’s a little easier to create a model for how we should stagger employee vaccinations when we know how commonly [side effects] are occurring and with what severity,” Biddinger said. Plans could change when more robust data becomes available, he added.
Though the pharmaceutical companies have yet to release full results from their largest trials, disclosures from earlier tests in recent press releases give a sense of their safety profiles.
A medical staff member treats a patient at the Covid-19 Intensive Care Unit of a hospital in Houston, Texas on Nov. 8.
Photographer: Go Nakamura/Bloomberg
Pfizer and its German partner BioNTech SE said on Nov. 18 that no serious safety concerns were observed in their late-stage trial. Among participants who got the two-dose vaccine regimen, 3.8% experienced fatigue, and 2% had headaches. Older adults reported fewer and milder adverse events. In an earlier trial, the companies identified cases of mild-to-moderate fever.
Moderna, meanwhile, said on Nov. 16 that it had also identified no serious safety concerns in its late-stage trial. Mild-to-moderate side effects included fatigue (9.7%), muscle or joint pain (5.2%) headache (4.5%) and injection-site pain (2.7%). The side effects were more common after the second dose of the two-dose vaccine.
Gallery: 6 Things That Put You More at Risk for Coronavirus (ETNT Health)
“We have been very reassured that we have not seen cases of things we would not expect,” said Buddy Creech, the director of Vanderbilt Vaccine Research Program who is leading trials of Covid-19 vaccines. “We see side effect profiles that are common to other vaccines we use.”
Small Proportion
Only a small proportion of those who get coronavirus vaccines will confront side effects, according to Creech, who also serves as the principal investigator for both Moderna and Johnson & Johnson’s Phase 3 clinical trials.
Remember, “it’s not 100% of people who have fevers and chills,” Creech said Thursday during a media panel held by the Infectious Disease Society of America, of which he is a member.
However, the potential that there might be side-effects strong enough to put health workers out of commission needs to be raised before the vaccination campaign begins, Creech said.
Read More: Hospitals Race to Set Vaccine Priorities for Health-Care Workers
If the possibility isn’t effectively communicated, he added, hospitals might be left understaffed. At the same time, medical workers must also be taught to distinguish between side effects from the vaccine and symptoms from Covid-19, given they are highly exposed to the virus.
“We will need to be somewhat strategic about who is offered the vaccine, so we’re working with clinical leads in those areas to make sure they stagger out their health-care personnel,” said Jeanmarie Mayer, chief of infection prevention at University of Utah Health, said Thursday at a press conference.
End of Shift
Utah-based Intermountain Healthcare is one system that may vaccinate workers at the end of their shifts before they have a few days off, said Kristin Dascomb, the medical director of infection prevention and employee health.
“When you’re having your weekend off, you might have the opportunity to have the symptoms, as mild as they might be, so that you’re not taking time off away from work when we are stressing caregivers at this time,” Dascomb said at the news conference.
Hospitals are generally planning to prioritize staff who work directly with coronavirus patients since they are at the greatest risk of contracting the disease on the job.
Mass General’s Biddinger worries health-care workers who confront unexpected symptoms might panic and think the shots are faulty, sowing even more mistrust among an already skeptical public.
“We’re trying to be very honest about what people should expect when they get the vaccine, but to remind them that it’s a good thing and it actually means that vaccination is helping us get more immune,” he said.
For more articles like this, please visit us at bloomberg.com
Marie
Veteran Member
Video stating cdc filed patents for the human isolated coronavirus and all testing and remedies.
@David52 - David52 - Difficult to believe it was not planned
this is parler linking to facebook run time 7min 14 sec
Then the link to the actual patent filed by cdc which is too huge to insert content
https://patents.google.com/patent/US7776521B1/en?oq=Us7776521b1
Here is the you tube video same run time
View: https://youtu.be/DlfvfMgGDEg
@David52 - David52 - Difficult to believe it was not planned
this is parler linking to facebook run time 7min 14 sec
Then the link to the actual patent filed by cdc which is too huge to insert content
https://patents.google.com/patent/US7776521B1/en?oq=Us7776521b1
Here is the you tube video same run time
marsh
On TB every waking moment
18:52 min
COVID-19 Vaccine (finally)
•Dec 7, 2020
Doctor Mike Hansen
COVID-19 Vaccine (Pfizer / BioNTech, Moderna, AstraZeneca, Novavax) *Correction - It Should be Pfizer (not "Phizer") (1:43) How is it possible a vaccine that under normal circumstances would take years to approve could be ready to roll out so quickly, and prove to be safe? (3:30) What are the vaccines (Moderna, Pfizer/BioNTech) and how do they work? (6:03) Side Effects and Safety (6:35) Efficacy (How effective are they?) (7:31) How long does the protection last? (7:31) Does it protect against asymptomatic disease? (7:31) Does it prevent people from spreading the virus to others? (8:26) Do I still need vaccine if I had covid? (8:39) Is the vaccine safe for me with my underlying medical condition? (8:59) Why do the mRNA vaccines (Phizer and Moderna) require super cold temperatures? (13:04) Who can get the vaccine? And When? (16:44) What restrictions will need to remain in place and for how long? (17:53) Are mutations going to affect the vaccination?
We’re talking about the Pfizer/BioNTech and Moderna vaccines here. Then there are other vaccines that are on the horizon as well, that are not mRNA vaccines. There are 6 vaccines getting some kind of federal government support in the US and dozens in being developed around the world. Several of these are in Phase 3 clinical trials, which is the last step before seeking the go-ahead from the FDA. With the 2 vaccines from Phizer and Moderna, they synthetically make messenger RNA, which is a genetic blueprint that signals to the cells of the body to start manufacturing a specific protein in the body. Not just any protein, but part of the spike protein of the virus. The body’s immune system then says, “hey we don’t recognize this spike protein guy, we should kick him out of the club. “So the immune system reacts accordingly. Except when the immune system reacts accordingly, it’s a whole cascade of events, with white blood cells causing a whole bunch of commotion, sending chemical signals to other parts of the body thru the blood, with cytokines, interferons, interleukins…and antibodies are made, which are proteins that bind to pieces of foreign invaders, so that the body is protected the next go around. Anyway, in this process, sometimes causes symptoms to develop, like some arm pain, maybe a little fever, body aches, headache, sometimes nausea, fatigue. And this is what sometimes happens with the flu shot. People sometimes think they got the flu from the flu shot, but that’s never the case. It was the immunological reaction to the vaccination. But back to these mRNA vaccines for COVID-19. They come in 2 doses, to be taken a few weeks apart. Why? Because the 1st dose, also known as the prime dose, although it does the job, its less than ideal, meaning the level of protective antibodies that develop, they’re there (show hand), but we want them up here (raise hand) to offer better protection. So with the prime dose, the antibodies take 2 weeks to develop. But then we want the second dose, the booster, to get the immune system reactivated. Once that re-activation takes place, immunogenicity is achieved, typically 7-10 days after the booster is given. And when people do experience the immune reactions from the mRNA COVID-19 vaccines, it’s not with the 1st dose, its after the booster.
The independent board that analyzes the participants in the study, found that severe side effects included fatigue in (9.7%), muscle pain (8.9%), joint pain (5.2%), and headache (4.5%). Less than 2% had fevers of 39°C to 40°C that lasted a day or two. For the Pfizer/BioNTech vaccine, the numbers were lower: Severe side effects included fatigue (3.8%) and headache (2%). Now compared to the flu shot, including the high-dose flu shot, thest numbers are slightly higher. But otherwise, the trials showed that these vaccines are safe. And they’re very, very effective. In Moderna’s clinical trial, they gave either the vaccine or a placebo to 30,000 people. Of the 15,000 who received the vaccine, 11 developed Covid-19. Of the 15,000 who received the placebo, 185 developed Covid-19. That’s 94.1% efficacy. None of the 11 people who received the vaccine became severely ill, but 30 of the 185 who received the placebo became severely ill, and one of them died. The vaccine had similar efficacy rates for elderly people and for people in racial minority groups. In Pfizer's clinical trial, the vaccine proved to be 95% effective, and one study participant who received the vaccine developed a severe case of Covid-19. So both of them giving 95% efficacy against symptomatic disease, and almost 100% against severe disease.
jazzy
Advocate Discernment
Urgent message from Robert F. Kennedy, Jr.: Avoid the Corona vaccine at all costs
This is an urgent message from Robert F. Kennedy, Jr., son of Robert F. Kennedy and nephew of former president John F. Kennedy. to all people around the world.
In summary: The Covid vaccine should be avoided at all costs. Learn why below!
“I would like to urgently draw your attention to important questions linked to the next vaccination against Covid-19.
“For the first time in the history of vaccination, the so-called mRNA vaccines of the latest generation intervene directly in the genetic material of the patient and therefore alter his individual genetic material, which represents genetic manipulation, which was already prohibited and hitherto considered criminal.
“This intervention can be compared to genetically modified foods, which are also very controversial.
(this article also has a video of interview with dr wolfgang wodarg who is great at explang whats going on and why this is so bad for people and the scam going on run time 9:53))
“As experienced physician Dr Wolfgang Wodarg said: Actually this “promising vaccine” for the vast majority of people should be BANNED because it is genetic engineering!“
strangesounds.org
This is an urgent message from Robert F. Kennedy, Jr., son of Robert F. Kennedy and nephew of former president John F. Kennedy. to all people around the world.
In summary: The Covid vaccine should be avoided at all costs. Learn why below!
“I would like to urgently draw your attention to important questions linked to the next vaccination against Covid-19.
“For the first time in the history of vaccination, the so-called mRNA vaccines of the latest generation intervene directly in the genetic material of the patient and therefore alter his individual genetic material, which represents genetic manipulation, which was already prohibited and hitherto considered criminal.
“This intervention can be compared to genetically modified foods, which are also very controversial.
(this article also has a video of interview with dr wolfgang wodarg who is great at explang whats going on and why this is so bad for people and the scam going on run time 9:53))
“As experienced physician Dr Wolfgang Wodarg said: Actually this “promising vaccine” for the vast majority of people should be BANNED because it is genetic engineering!“
Why you should avoid the Corona vaccine at all costs - Strange Sounds
This is why you should avoid the corona vaccines at all costs. The new vaccines are genetic engineering
strangesounds.org
Melodi
Disaster Cat
I can't wait to show this one to Nightwolf (he's sleeping in he was up late) - looks like I am now excused from taking this as well - or as my husband observed last now, they already can't get "herd" immunity (even if the vaccine works as hoped) if no women of childbearing age can get it without proof of not being pregnant and now people with significant allergies of any kind - mine is shellfish, which means I also had a reaction when they injected the blue dye into me for a scan years ago (now we know and I warn the techs) as it is (or was at the time) made from shellfish. - Melodi
news.sky.com
COVID-19 vaccine: UK regulators warn people with history of 'significant' allergic reactions not to have Pfizer/BioNTech jab
Wednesday 9 December 2020 10:20, UK
Image:Two NHS staff members are recovering after suffering a reaction from the Pfizer jab
UK regulators have issued a warning that people who have a history of "significant" allergic reactions should not currently receive the Pfizer/BioNTech vaccine.
Two NHS staff members who had the jab yesterday experienced allergic reactions, and are understood to be recovering.
Sponsored link
Recommended by
The UK became the first country in the world to approve the Pfizer vaccine last week, and yesterday began vaccinating care home and hospital patients and NHS staff, among others.
Follow live updates as Whitty and Vallance face questions on UK's response to pandemic
Professor Stephen Powis, national medical director for the NHS in England, said: "As is common with new vaccines the MHRA have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination after two people with a history of significant allergic reactions responded adversely yesterday. Both are recovering well."
Advertisement
The NHS in England said all trusts involved with the vaccination programme have been informed.
The Medicines and Healthcare products Regulatory Agency (MHRA) has given precautionary advice to NHS trusts that anyone who has a history of "significant" allergic reactions to medicines, food or vaccines should not receive the vaccine.
More from UK
COVID-19 vaccine: UK regulators warn people with history of 'significant' allergic reactions not to have Pfizer/BioNTech jab
UK regulators have issued a warning that people who have a history of "significant" allergic reactions should not currently receive the Pfizer/BioNTech vaccine.
news.sky.com
Wednesday 9 December 2020 10:20, UK
Image:Two NHS staff members are recovering after suffering a reaction from the Pfizer jab
UK regulators have issued a warning that people who have a history of "significant" allergic reactions should not currently receive the Pfizer/BioNTech vaccine.
Two NHS staff members who had the jab yesterday experienced allergic reactions, and are understood to be recovering.
Sponsored link
Recommended by
IBM Cloud Pak for Data: Reduce costs and…IBMThe UK became the first country in the world to approve the Pfizer vaccine last week, and yesterday began vaccinating care home and hospital patients and NHS staff, among others.
Follow live updates as Whitty and Vallance face questions on UK's response to pandemic
Professor Stephen Powis, national medical director for the NHS in England, said: "As is common with new vaccines the MHRA have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination after two people with a history of significant allergic reactions responded adversely yesterday. Both are recovering well."
Advertisement
The NHS in England said all trusts involved with the vaccination programme have been informed.
The Medicines and Healthcare products Regulatory Agency (MHRA) has given precautionary advice to NHS trusts that anyone who has a history of "significant" allergic reactions to medicines, food or vaccines should not receive the vaccine.
More from UK
Melodi
Disaster Cat
Oh this just gets "better and better" now we might need jabs every nine months! what?...Melodi
news.sky.com
COVID news live – latest UK updates: Whitty and Vallance being quizzed - and say most vulnerable may need vaccine again in 9 months
Latest coronavirus news as over-80s, healthcare workers and care home residents start getting the vaccine.
COVID news live – UK updates: Matt Hancock warns virus is 'doubling in seven days' in some areas as tighter restrictions brought in
All the latest COVID updates from the UK and across the world.
news.sky.com
Latest coronavirus news as over-80s, healthcare workers and care home residents start getting the vaccine.
Melodi
Disaster Cat
HEALTH AND SCIENCE
The FDA says Pfizer’s Covid vaccine is safe and effective. But trial participants warn of intense symptoms after second shot
PUBLISHED TUE, DEC 8 20203:31 PM ESTUPDATED TUE, DEC 8 20208:40 PM EST
MacKenzie Sigalos@KENZIESIGALOS
Under the Pfizer-BioNtech deal, the 27 EU countries could buy 200 million doses, and have an option to purchase another 100 million.
NurPhoto | Getty Images
KEY POINTS
If Pfizer’s shot is granted an emergency use authorization, or EUA, the immunizations — which are administered in two doses about three weeks apart — could start as soon as next week.
Many people are now wondering whether this will be just like getting the flu vaccine.
The short answer is: No, not really.
WATCH NOW
VIDEO02:02
FDA report finds Pfizer Covid vaccine safe and effective
One Pfizer trial participant told CNBC that after the second shot, he woke up with chills, shaking so hard he cracked a tooth. “It hurt to even just lay in my bed sheet,” he said.
Others experienced headaches and fatigue.
The FDA said that while side effects of the Pfizer vaccine are common, there are “no specific safety concerns identified that would preclude issuance of an EUA.”
Be prepared for the second shot
The Pfizer vaccine is one of four U.S.-backed candidates in phase three trials. Next up is one from U.S. biotech firm Moderna, which has also submitted its EUA application.
Both companies have said that taking their vaccines could result in side effects similar to mild Covid symptoms. Think muscle pain, chills and a headache.
Source: Yasir Batalvi
When trial participant Yasir Batalvi first read Moderna’s 22-page consent form warning of side effects ranging from nothing at all to death, he felt pretty worried, he told CNBC.
“You have to keep in mind, I joined the trial when we didn’t know it was going to be a safe vaccine,” said Batalvi, a recent college graduate living in Boston.
The 24-year-old said that when he got the first injection in mid-October, it felt just like a flu shot. “I experienced stiffness and pain in my left arm where I had gotten the shot, but it was mild,” he explained. “By that evening, I didn’t want to move my arm above my shoulder, but it was localized, and it disappeared by the next day.”
The second dose was a different story.
“After the injection, I had the same side effects as the first: localized pain and stiffness, but it was a little bit worse. My arm got sore faster, and by the time I got home, I started feeling fatigued and like anyone would feel if they were coming down with the flu,” said Batalvi.
More significant symptoms presented that evening. “I developed a low-grade fever and had chills,” he said. “That evening was rough.”
Moderna stopped testing the highest dose of its vaccine during the trial because of the number of reports of severe adverse reactions.
As for any long-term effects, Batalvi isn’t giving it much thought. “I’m not too concerned,” he said. “We know from vaccination trials that any adverse events mostly show up in the first couple of months.”
How an mRNA vaccine works
Front-runners Pfizer and Moderna built their candidates with a new kind of technology that’s never before been licensed in the U.S.
Messenger RNA vaccines, called mRNA for short, aren’t like your normal flu vaccine. Typically, a vaccine puts a weakened or inactivated virus into our bodies to trigger an immune response, which then produces antibodies. Those antibodies are what ultimately protect us from getting infected if we ever encounter the real thing.
An mRNA vaccine, on the other hand, is essentially just a piece of genetic code that contains instructions for our body. The mRNA tells our cells to make a protein — the same protein that is the spike on top of the actual coronavirus. This is what triggers the immune response in these types of vaccines.
So even though some trial participants reported Covid-like symptoms, it is impossible to contract the coronavirus from the vaccine, because the mRNA vaccines that Pfizer and Moderna are making don’t use the live virus.
Source: Yasir Batalvi
Dr. Hana El Sahly, who oversees a clinical trial for Moderna’s vaccine candidate, said one major benefit of the mRNA technology is how fast it is to make. “The attractiveness of it is the speed with which it can be manufactured once we know the sequence of the virus,” said El Sahly.
With the traditional flu vaccine, you have to first grow the virus in an egg, then deactivate the virus, and finally, put it into vaccine vials with either mRNA or recombinant DNA technology, explained El Sahly.
The Covid vaccine’s faster manufacturing timeline is key, as distributors look to expedite distribution to the U.S. population.
Paying for the vaccine
Also key to widespread vaccination is making sure governments around the world have enough money to buy the vaccines.
Moderna said in August it is charging between $32 and $37 per dose for its vaccine and would perhaps offer a discount if it is bought in bulk. Pfizer’s, on the other hand, is more affordable. It is reportedly $20 per dose.
The U.S. has secured 100 million doses of the Pfizer vaccine, which is enough to vaccinate 50 million people.
But to achieve herd immunity, experts say, roughly 70% of the population needs to be vaccinated or have natural antibodies. That’s about 462 million doses for herd immunity and an estimated 660 million doses for everyone in the country.
Pfizer board member Dr. Scott Gottlieb told CNBC on Tuesday that President Donald Trump declined the company’s offer to buy additional doses.
A debate over unblinding the control group
Both Pfizer and Moderna are conducting double-blind trials, which means that half the participants receive a placebo and the other half receive the actual vaccine. Because the trials are ongoing, it also means that patients don’t know which group they are in.
There is a debate raging among experts about whether to give the control group the vaccine.
The FDA isn’t too keen on the idea of dosing the placebo group, while some scientists are making the case that they should be moved higher on the prioritization list as a thanks for their service.
But this kind of break in trial protocol would interfere with the integrity of the trial, so for now, participants such as Batalvi remain in the dark as to whether they’re actually protected against the virus. A person can still present symptoms, as Batalvi did, even if they are in the control group. It’s the “placebo effect.”
But either way, Batalvi said he’s glad he had the opportunity to participate in an effort to protect the world against the pandemic.
The FDA says Pfizer’s Covid vaccine is safe and effective. But trial participants warn of intense symptoms after second shot
PUBLISHED TUE, DEC 8 20203:31 PM ESTUPDATED TUE, DEC 8 20208:40 PM EST
MacKenzie Sigalos@KENZIESIGALOS
Under the Pfizer-BioNtech deal, the 27 EU countries could buy 200 million doses, and have an option to purchase another 100 million.
NurPhoto | Getty Images
KEY POINTS
- The FDA said data from Pfizer’s Covid vaccine trials show that side effects are common, though there are “no specific safety concerns identified that would preclude issuance of an” emergency use authorization.
- Trial participants in the Moderna and Pfizer studies told CNBC they developed more significant symptoms following the second dose.
If Pfizer’s shot is granted an emergency use authorization, or EUA, the immunizations — which are administered in two doses about three weeks apart — could start as soon as next week.
Many people are now wondering whether this will be just like getting the flu vaccine.
The short answer is: No, not really.
WATCH NOW
VIDEO02:02
FDA report finds Pfizer Covid vaccine safe and effective
One Pfizer trial participant told CNBC that after the second shot, he woke up with chills, shaking so hard he cracked a tooth. “It hurt to even just lay in my bed sheet,” he said.
Others experienced headaches and fatigue.
The FDA said that while side effects of the Pfizer vaccine are common, there are “no specific safety concerns identified that would preclude issuance of an EUA.”
Be prepared for the second shot
The Pfizer vaccine is one of four U.S.-backed candidates in phase three trials. Next up is one from U.S. biotech firm Moderna, which has also submitted its EUA application.
Both companies have said that taking their vaccines could result in side effects similar to mild Covid symptoms. Think muscle pain, chills and a headache.
Source: Yasir Batalvi
When trial participant Yasir Batalvi first read Moderna’s 22-page consent form warning of side effects ranging from nothing at all to death, he felt pretty worried, he told CNBC.
“You have to keep in mind, I joined the trial when we didn’t know it was going to be a safe vaccine,” said Batalvi, a recent college graduate living in Boston.
The 24-year-old said that when he got the first injection in mid-October, it felt just like a flu shot. “I experienced stiffness and pain in my left arm where I had gotten the shot, but it was mild,” he explained. “By that evening, I didn’t want to move my arm above my shoulder, but it was localized, and it disappeared by the next day.”
The second dose was a different story.
“After the injection, I had the same side effects as the first: localized pain and stiffness, but it was a little bit worse. My arm got sore faster, and by the time I got home, I started feeling fatigued and like anyone would feel if they were coming down with the flu,” said Batalvi.
More significant symptoms presented that evening. “I developed a low-grade fever and had chills,” he said. “That evening was rough.”
After a restless night, he called the study doctors, who reassured him it was a normal reaction and no cause for concern. By that afternoon, Batalvi said, he felt like himself again.
Moderna stopped testing the highest dose of its vaccine during the trial because of the number of reports of severe adverse reactions.
As for any long-term effects, Batalvi isn’t giving it much thought. “I’m not too concerned,” he said. “We know from vaccination trials that any adverse events mostly show up in the first couple of months.”
How an mRNA vaccine works
Front-runners Pfizer and Moderna built their candidates with a new kind of technology that’s never before been licensed in the U.S.
Messenger RNA vaccines, called mRNA for short, aren’t like your normal flu vaccine. Typically, a vaccine puts a weakened or inactivated virus into our bodies to trigger an immune response, which then produces antibodies. Those antibodies are what ultimately protect us from getting infected if we ever encounter the real thing.
An mRNA vaccine, on the other hand, is essentially just a piece of genetic code that contains instructions for our body. The mRNA tells our cells to make a protein — the same protein that is the spike on top of the actual coronavirus. This is what triggers the immune response in these types of vaccines.
So even though some trial participants reported Covid-like symptoms, it is impossible to contract the coronavirus from the vaccine, because the mRNA vaccines that Pfizer and Moderna are making don’t use the live virus.
Source: Yasir Batalvi
Dr. Hana El Sahly, who oversees a clinical trial for Moderna’s vaccine candidate, said one major benefit of the mRNA technology is how fast it is to make. “The attractiveness of it is the speed with which it can be manufactured once we know the sequence of the virus,” said El Sahly.
With the traditional flu vaccine, you have to first grow the virus in an egg, then deactivate the virus, and finally, put it into vaccine vials with either mRNA or recombinant DNA technology, explained El Sahly.
The Covid vaccine’s faster manufacturing timeline is key, as distributors look to expedite distribution to the U.S. population.
Paying for the vaccine
Also key to widespread vaccination is making sure governments around the world have enough money to buy the vaccines.
Moderna said in August it is charging between $32 and $37 per dose for its vaccine and would perhaps offer a discount if it is bought in bulk. Pfizer’s, on the other hand, is more affordable. It is reportedly $20 per dose.
The U.S. has secured 100 million doses of the Pfizer vaccine, which is enough to vaccinate 50 million people.
But to achieve herd immunity, experts say, roughly 70% of the population needs to be vaccinated or have natural antibodies. That’s about 462 million doses for herd immunity and an estimated 660 million doses for everyone in the country.
Pfizer board member Dr. Scott Gottlieb told CNBC on Tuesday that President Donald Trump declined the company’s offer to buy additional doses.
A debate over unblinding the control group
Both Pfizer and Moderna are conducting double-blind trials, which means that half the participants receive a placebo and the other half receive the actual vaccine. Because the trials are ongoing, it also means that patients don’t know which group they are in.
There is a debate raging among experts about whether to give the control group the vaccine.
The FDA isn’t too keen on the idea of dosing the placebo group, while some scientists are making the case that they should be moved higher on the prioritization list as a thanks for their service.
But this kind of break in trial protocol would interfere with the integrity of the trial, so for now, participants such as Batalvi remain in the dark as to whether they’re actually protected against the virus. A person can still present symptoms, as Batalvi did, even if they are in the control group. It’s the “placebo effect.”
But either way, Batalvi said he’s glad he had the opportunity to participate in an effort to protect the world against the pandemic.
Melodi
Disaster Cat
A little more information on this is coming out - the UK regulator will require this but I don't know if the US will also do so, if the US tries to cover this up, then it should be shouted from the highest rooftop. An elderly person with such an allergic reaction (note they define it as anaphylaxis in this RTE article) would be more likely to die than to "recover well" this is the one I get from shellfish where people can stop breathing pretty fast with immediate medical attention (like in the next 5 to 20 minutes). This is HUGE, because so many people not only have bad drug reactions but have anaphylactic responses to peanuts, milk, shellfish, and some other foods. Like my nephew they may not even know they have an allergy until they suddenly do - I only still have a living nephew because the school nurse in North Carolina had an epi-pen. - Melodi
www.rte.ie
UK regulator issues allergy warning over Covid vaccine
Updated / Wednesday, 9 Dec 2020 10:46
The UK has begun a Covid-19 vaccination programme
UK regulators have issued a warning that people who have a history of "significant" allergic reactions should not currently receive the Pfizer/BioNTech Covid-19 vaccine after two people who had the jab yesterday had allergic reactions.
Two NHS staff members who received the vaccine on the first day of the mass vaccination programme suffered an allergic reaction, the NHS in England has confirmed.
The Medicines and Healthcare products Regulatory Agency (MHRA) has given precautionary advice to NHS trusts that anyone who has a history of "significant" allergic reactions to medicines, food or vaccines should not receive the vaccine.
The NHS in England said all trusts involved with the vaccination programme have been informed.
This means that anyone scheduled to receive the vaccine today will be asked about their history of allergic reactions.
Latest coronavirus stories
Professor Stephen Powis, national medical director for the NHS in England, said: "As is common with new vaccines, the MHRA have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination after two people with a history of significant allergic reactions responded adversely yesterday.
"Both are recovering well."
The MHRA advice states: "Any person with a history of a significant allergic reaction to a vaccine, medicine or food (such as previous history of anaphylactoid reaction or those who have been advised to carry an adrenaline autoinjector) should not receive the Pfizer/BioNtech vaccine.
"Resuscitation facilities should be available at all times for all vaccinations. Vaccination should only be carried out in facilities where resuscitation measures are available."
It is understood that both the staff members had a significant history of allergic reactions - to the extent where they need to carry an adrenaline auto injector with them.
They developed symptoms of "anaphylactoid reaction" shortly after receiving the vaccine and both have recovered after the appropriate treatment.
Pfizer said the vaccine was "well tolerated" during the trials with "no serious safety concerns".
A spokeswoman said: "We have been advised by MHRA of two yellow card reports that may be associated with allergic reaction due to administration of the Covid-19 BNT162b2 vaccine.
"As a precautionary measure, the MHRA has issued temporary guidance to the NHS while it conducts an investigation in order to fully understand each case and its causes. Pfizer and BioNTech are supporting the MHRA in the investigation.
"In the pivotal phase three clinical trial, this vaccine was generally well tolerated with no serious safety concerns reported by the independent Data Monitoring Committee.
The trial has enrolled over 44,000 participants to date, over 42,000 of whom have received a second vaccination."
UK regulator issues allergy warning over Covid vaccine
UK regulators have issued a warning that people who have a history of "significant" allergic reactions should not currently receive the Pfizer/BioNTech Covid-19 vaccine after two people who had the jab yesterday had allergic reactions.
Updated / Wednesday, 9 Dec 2020 10:46
The UK has begun a Covid-19 vaccination programme
UK regulators have issued a warning that people who have a history of "significant" allergic reactions should not currently receive the Pfizer/BioNTech Covid-19 vaccine after two people who had the jab yesterday had allergic reactions.
Two NHS staff members who received the vaccine on the first day of the mass vaccination programme suffered an allergic reaction, the NHS in England has confirmed.
The Medicines and Healthcare products Regulatory Agency (MHRA) has given precautionary advice to NHS trusts that anyone who has a history of "significant" allergic reactions to medicines, food or vaccines should not receive the vaccine.
The NHS in England said all trusts involved with the vaccination programme have been informed.
This means that anyone scheduled to receive the vaccine today will be asked about their history of allergic reactions.
Latest coronavirus stories
Professor Stephen Powis, national medical director for the NHS in England, said: "As is common with new vaccines, the MHRA have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination after two people with a history of significant allergic reactions responded adversely yesterday.
"Both are recovering well."
The MHRA advice states: "Any person with a history of a significant allergic reaction to a vaccine, medicine or food (such as previous history of anaphylactoid reaction or those who have been advised to carry an adrenaline autoinjector) should not receive the Pfizer/BioNtech vaccine.
"Resuscitation facilities should be available at all times for all vaccinations. Vaccination should only be carried out in facilities where resuscitation measures are available."
It is understood that both the staff members had a significant history of allergic reactions - to the extent where they need to carry an adrenaline auto injector with them.
They developed symptoms of "anaphylactoid reaction" shortly after receiving the vaccine and both have recovered after the appropriate treatment.
Pfizer said the vaccine was "well tolerated" during the trials with "no serious safety concerns".
A spokeswoman said: "We have been advised by MHRA of two yellow card reports that may be associated with allergic reaction due to administration of the Covid-19 BNT162b2 vaccine.
"As a precautionary measure, the MHRA has issued temporary guidance to the NHS while it conducts an investigation in order to fully understand each case and its causes. Pfizer and BioNTech are supporting the MHRA in the investigation.
"In the pivotal phase three clinical trial, this vaccine was generally well tolerated with no serious safety concerns reported by the independent Data Monitoring Committee.
The trial has enrolled over 44,000 participants to date, over 42,000 of whom have received a second vaccination."
Macgyver
Has No Life - Lives on TB
Four Volunteers Who Took Pfizer's COVID-19 Vaccine Developed Bell's Palsy - FDA Denies the Temporary Facial Paralysis Caused by the Shot | The Gateway Pundit | by Joe Hoft
Breaking news – Daily Mail reports that at least four individuals contracted Bell’s Palsy after taking Pfizer’s COVID-19 Vaccine. Relations between Pfizer and China also in question.
www.thegatewaypundit.com
Four Volunteers Who Took Pfizer's COVID-19 Vaccine Developed Bell's Palsy - FDA Denies the Temporary Facial Paralysis Caused by the Shot
Joe Hoft
3-4 minutes
Breaking news – Daily Mail reports that at least four individuals contracted Bell’s Palsy after taking Pfizer’s COVID-19 Vaccine. Relations between Pfizer and China also in question.
The vaccine business is big money for Big Pharma – the large corporations that benefit from the production of vaccines. This was summarized by Bobby Kennedy, Jr. months ago as he listed the protections these companies receive from the US government (similar in the manner Big Tech is protected):
The list of side effects from the COVID vaccine have previously been reported, but this morning Daily Mail reports that recent cases of Bells palsy developed from the Pfizer trial:
TRENDING: Allen West: Seven States Will Join Texas in SCOTUS Lawsuit Against Georgia, Michigan, Wisconsin and Pennsylvania
On November 13, MSM reported on the Pfizer’s progress:
What was not mentioned in the above report was that Pfizer had signed an agreement in August with Gilead.
And Gilead and Dr. Fauci were working with China in February mass producing Remdesivir:
It’s a wonder that 50% of Americans don’t want to take a COVID vaccine. This should never be mandatory.
forpetesake
Senior Member
I recently learned that the vaccine will NOT be mandatory for HCW in our area, at least.
Melodi
Disaster Cat
With what is coming out, Nightwolf thinks it will dash all those lovely "plans" for COVID "Passports" and the like at least temporarily.
Heck women could sue if they can't get a card because of gender and medical disability (if pregnant) and I could sue on grounds of disability (as can anyone else with a history of serious allergic reactions).
Now that said, they might try it with the "next" vaccine if that seems a bit less of a problem with so many people, but for the short term it is such proposals are now DOA.
Melodi
Disaster Cat
New Headline and update on the Daily Mail Article (typically they will keep the same article going for several days) entire thing can be read at the link, but article amits that the UK government is trying to stop "panic" among the UK public (this is also linked on Drudge as the main headline which surprised me).
www.dailymail.co.uk
Calls for calm over Pfizer vaccine roll-out after two NHS staff suffer 'anaphylactoid reaction': Scientists urge public not to panic after regulators warn people with history of 'significant' allergies NOT to have jab
PUBLISHED: 09:56, 9 December 2020 | UPDATED: 18:57, 9 December 2020
WHAT ARE THE KNOWN SIDE EFFECTS FROM THE PFIZER VACCINE?
The UK medicines regulator advised today that anyone who has a history of 'significant' allergic reactions to medicines, food or vaccines should not get the Pfizer coronavirus jab.
Dr June Raine, the chief executive of the MHRA, told Parliament's Science and Technology Committee that this was not identified in the trials.
'We know from very extensive clinical trials that this wasn't a feature,' she said.
Allergic reactions to the vaccine are 'very rare', according to the trials involving more than 40,000 people.
Pfizer found a 'very small number' during its phase three clinical studies, or 137 out of 19,000 people who got the vaccine.
They also identified 12 possible side-effects from the vaccine, with seven identified as 'very common' meaning they are likely to affect more than one in ten people. Below are the known side effects.
The patient safety leaflet for the vaccine cautions that anyone with an allergy to any of the active substances in the vaccine should not receive the jab.
It adds: 'Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue.'
Allergic reactions to the vaccine are:
Very common (Likely to affect more than one in ten people)
British scientists today attempted to quash public panic about the Pfizer/BioNTech vaccine which is currently being rolled-out across the country, following reports that two NHS staff suffered an 'anaphylactoid reaction' just after being immunised on V-Day yesterday.
Within 24 hours of the biggest-ever mass vaccination programme in British history, the UK's drug regulator told anyone with a serious allergy to medicines or food was told not to have the much-vaunted jab.
The number of people set to be barred is not known, though up to seven million people in the country have allergies severe enough to require medical care, according to the NHS – while around 250,000 people need to carry an EpiPen at all times.
Both the unnamed healthcare workers needed immediate treatment but are 'recovering well' after they developed symptoms shortly after receiving the jab. It is not known if either person needed to use the EpiPens they both carry with them at all times.
They suffered an 'anaphylactoid reaction' to the vaccine, which is milder than anaphylaxis, and tends to involve a rash, shortness of breath, swelling of the face and tongue or a drop in blood pressure, the NHS says.
Despite the two allergy cases the Government is today continuing to vaccinate between 5,000 and 7,000 people per day across the UK with 800,000 Pfizer doses already in hospitals and millions more on the way.
Today the Medicines and Healthcare products Regulatory Agency (MHRA) – which authorised emergency use of the vaccine at a breathtaking speed – gave precautionary advice to all 50 NHS trusts now vaccinating the population that anyone who has a history of 'significant' allergic reactions to medicines or food should not receive the vaccine.
However, British scientists today called for calm as public fears of the alleged dangers of the new vaccine - which is said to have an 95 per cent efficacy against infection – threaten to derail the NHS' mass inoculation programme in the latest stage of the pandemic.
Professor Graham Ogg of Oxford University urged calm, saying: 'It will be important to now understand the specific nature of the reactions and the background medical history of the individuals affected so that any risks of reactions can be more closely defined. Staff are always prepared for the possibility of reactions and as with all medications, will continue to submit reports of any further episodes. In the meantime, reasonable precautions have been advised by the MHRA.'
Dr Andrew Garrett, Executive Vice President of Scientific Operations at ICON, pointed out: 'The large clinical trial used to support vaccine approval by the MHRA excluded those with a 'History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (e.g. anaphylaxis) to any component of the study intervention(s)'.
'The resulting UK patient leaflet stated that the vaccine should not be given to individuals who are allergic to the active substance or any of the other listed ingredients. In this respect the patient information was similar to the clinical trial exclusion criterion, and the approved vaccine labelling will have reflected the data received and reviewed by the MHRA to date.
'As more data accumulate from both clinical trials and clinical practice then one naturally expects the safety profile to be updated and refined, as with any medicine.
'The MHRA has moved quickly today to strengthen their direction on the basis of two allergic reactions in individuals with a history of allergic reactions – that is, to exclude individuals with a significant history of allergic reactions moving forward.'
He added: 'Tuesday was a welcome cause for celebration, and there was an enthusiastic response from those vaccinated. Labelling may well expand in the future, but it would be wise to be cautious in these early days to avoid undermining public confidence – particularly given the vaccine is in limited supply. Careful questioning of those about to receive the vaccine is in order.'
Dr Penny Ward of King's College London and Chair of the Education and Standards Committee of the Faculty of Pharmaceutical Medicine said: 'As these two events occurred in people with a history of severe allergy, it is sensible of the MHRA to draw attention to these reports and to suggest that individuals with a history of severe allergy not receive the vaccine at this time.
'MHRA is actively monitoring the safety of the vaccine during clinical use and can be expected to provide updates to practitioners as more information is gathered. The prompt reporting of these events using the yellow card scheme and the rapid issuing of additional information to guide practice shows that the safety monitoring system is working well.'
And Professor Peter Openshaw, past-President of the British Society for Immunology and Professor of Experimental Medicine at Imperial College London, said: 'As with all food and medications, there is a very small chance of an allergic reaction to any vaccine. However, it is important that we put this risk in perspective.
'The occurrence of any allergic reaction was one of the factors monitored in the phase 3 clinical trial of this Pfizer/BioNTech COVID-19 vaccine, the detailed data from which was released yesterday. In this, they reported a very small number of allergic reactions in both the vaccine and placebo groups (0.63% and 0.51%).
'Similar to the rollout of all new vaccines and medications, this new COVID-19 vaccine is being monitored closely by the Medicines and Healthcare products Regulatory Agency (MHRA). They will now investigate these cases in more detail to understand if the allergic reactions were linked to the vaccine or were incidental. The fact that we know so soon about these two allergic reactions and that the regulator has acted on this to issue precautionary advice shows that this monitoring system is working well.'
NHS England national medical director Professor Stephen Powis said: 'The MHRA have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination after two people with a history of significant allergic reactions responded adversely yesterday. Both are recovering well.'
In the US vaccine trial carried out by Pfizer, 137 out of around 19,000 people given the vaccine had one or more of these reactions. But 111 who got the placebo also had allergic reactions. Reactions to the jab can include a temperature, nausea, swelling of the arm or in severe cases feeling generally unwell with swollen lymph node glands.
A Pfizer spokesman said: 'We have been advised by MHRA of two yellow card reports that may be associated with allergic reaction due to administration of the COVID-19 BNT162b2 vaccine. As a precautionary measure, the MHRA has issued temporary guidance to the NHS while it conducts an investigation in order to fully understand each case and its causes. Pfizer and BioNTech are supporting the MHRA in the investigation.
'In the pivotal phase 3 clinical trial, this vaccine was generally well tolerated with no serious safety concerns reported by the independent Data Monitoring Committee. The trial has enrolled over 44,000 participants to date, over 42,000 of whom have received a second vaccination'.
The allergy scare came hours after Britain's drug regulator dismissed safety fears over the Pfizer/BioNTech coronavirus vaccine after a report revealed four people in a trial in the US got Bell's palsy. The condition, which is usually temporary, causes muscles on one side of the face to droop because of nerves not working properly.
Four cases of it were found in a group of 21,720 people who had the Pfizer vaccine in a trial in the US, compared to none among 21,728 people given a placebo vaccine. But this rate of occurrence is no different to how often it would be expected to happen in a random population, the company said.
Calls for calm over Covid vaccine roll-out amid allergy scare
Both the healthcare workers, who carried EpiPens, are recovering from anaphylactoid reactions following the first day of the mass vaccination programme.
- Both the people are recovering following the first day of the mass vaccination programme, it is understood
- In the US vaccine trial carried out by Pfizer, 137 out of around 19,000 people given vaccine had a reaction
- The NHS in England said that all the trusts involved with the vaccination programme have been informed
- MHRA has given advice anyone who has a history of 'significant' allergic reactions should not get the vaccine
- Yesterday the NHS embarked on its colossal plan to vaccinate the entire UK population against coronavirus
- Dr June Raine, chief executive of MHRA, told MPs today there had been two allergic reactions to the jab
- Have you or someone you know suffered a reaction to the jab? Email James.Gant@mailonline.co.uk
PUBLISHED: 09:56, 9 December 2020 | UPDATED: 18:57, 9 December 2020
WHAT ARE THE KNOWN SIDE EFFECTS FROM THE PFIZER VACCINE?
The UK medicines regulator advised today that anyone who has a history of 'significant' allergic reactions to medicines, food or vaccines should not get the Pfizer coronavirus jab.
Dr June Raine, the chief executive of the MHRA, told Parliament's Science and Technology Committee that this was not identified in the trials.
'We know from very extensive clinical trials that this wasn't a feature,' she said.
Allergic reactions to the vaccine are 'very rare', according to the trials involving more than 40,000 people.
Pfizer found a 'very small number' during its phase three clinical studies, or 137 out of 19,000 people who got the vaccine.
They also identified 12 possible side-effects from the vaccine, with seven identified as 'very common' meaning they are likely to affect more than one in ten people. Below are the known side effects.
The patient safety leaflet for the vaccine cautions that anyone with an allergy to any of the active substances in the vaccine should not receive the jab.
It adds: 'Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue.'
Allergic reactions to the vaccine are:
Very common (Likely to affect more than one in ten people)
- Pain at injection site
- Tiredness
- Muscle pain
- Chills
- Joint pain
- Fever
- Headache
- Injection site swelling
- Redness at injection site
- Nausea
- Enlarged lymph nodes
- Feeling unwell
British scientists today attempted to quash public panic about the Pfizer/BioNTech vaccine which is currently being rolled-out across the country, following reports that two NHS staff suffered an 'anaphylactoid reaction' just after being immunised on V-Day yesterday.
Within 24 hours of the biggest-ever mass vaccination programme in British history, the UK's drug regulator told anyone with a serious allergy to medicines or food was told not to have the much-vaunted jab.
The number of people set to be barred is not known, though up to seven million people in the country have allergies severe enough to require medical care, according to the NHS – while around 250,000 people need to carry an EpiPen at all times.
Both the unnamed healthcare workers needed immediate treatment but are 'recovering well' after they developed symptoms shortly after receiving the jab. It is not known if either person needed to use the EpiPens they both carry with them at all times.
They suffered an 'anaphylactoid reaction' to the vaccine, which is milder than anaphylaxis, and tends to involve a rash, shortness of breath, swelling of the face and tongue or a drop in blood pressure, the NHS says.
Despite the two allergy cases the Government is today continuing to vaccinate between 5,000 and 7,000 people per day across the UK with 800,000 Pfizer doses already in hospitals and millions more on the way.
Today the Medicines and Healthcare products Regulatory Agency (MHRA) – which authorised emergency use of the vaccine at a breathtaking speed – gave precautionary advice to all 50 NHS trusts now vaccinating the population that anyone who has a history of 'significant' allergic reactions to medicines or food should not receive the vaccine.
However, British scientists today called for calm as public fears of the alleged dangers of the new vaccine - which is said to have an 95 per cent efficacy against infection – threaten to derail the NHS' mass inoculation programme in the latest stage of the pandemic.
Professor Graham Ogg of Oxford University urged calm, saying: 'It will be important to now understand the specific nature of the reactions and the background medical history of the individuals affected so that any risks of reactions can be more closely defined. Staff are always prepared for the possibility of reactions and as with all medications, will continue to submit reports of any further episodes. In the meantime, reasonable precautions have been advised by the MHRA.'
Dr Andrew Garrett, Executive Vice President of Scientific Operations at ICON, pointed out: 'The large clinical trial used to support vaccine approval by the MHRA excluded those with a 'History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (e.g. anaphylaxis) to any component of the study intervention(s)'.
'The resulting UK patient leaflet stated that the vaccine should not be given to individuals who are allergic to the active substance or any of the other listed ingredients. In this respect the patient information was similar to the clinical trial exclusion criterion, and the approved vaccine labelling will have reflected the data received and reviewed by the MHRA to date.
'As more data accumulate from both clinical trials and clinical practice then one naturally expects the safety profile to be updated and refined, as with any medicine.
'The MHRA has moved quickly today to strengthen their direction on the basis of two allergic reactions in individuals with a history of allergic reactions – that is, to exclude individuals with a significant history of allergic reactions moving forward.'
He added: 'Tuesday was a welcome cause for celebration, and there was an enthusiastic response from those vaccinated. Labelling may well expand in the future, but it would be wise to be cautious in these early days to avoid undermining public confidence – particularly given the vaccine is in limited supply. Careful questioning of those about to receive the vaccine is in order.'
Dr Penny Ward of King's College London and Chair of the Education and Standards Committee of the Faculty of Pharmaceutical Medicine said: 'As these two events occurred in people with a history of severe allergy, it is sensible of the MHRA to draw attention to these reports and to suggest that individuals with a history of severe allergy not receive the vaccine at this time.
'MHRA is actively monitoring the safety of the vaccine during clinical use and can be expected to provide updates to practitioners as more information is gathered. The prompt reporting of these events using the yellow card scheme and the rapid issuing of additional information to guide practice shows that the safety monitoring system is working well.'
And Professor Peter Openshaw, past-President of the British Society for Immunology and Professor of Experimental Medicine at Imperial College London, said: 'As with all food and medications, there is a very small chance of an allergic reaction to any vaccine. However, it is important that we put this risk in perspective.
'The occurrence of any allergic reaction was one of the factors monitored in the phase 3 clinical trial of this Pfizer/BioNTech COVID-19 vaccine, the detailed data from which was released yesterday. In this, they reported a very small number of allergic reactions in both the vaccine and placebo groups (0.63% and 0.51%).
'Similar to the rollout of all new vaccines and medications, this new COVID-19 vaccine is being monitored closely by the Medicines and Healthcare products Regulatory Agency (MHRA). They will now investigate these cases in more detail to understand if the allergic reactions were linked to the vaccine or were incidental. The fact that we know so soon about these two allergic reactions and that the regulator has acted on this to issue precautionary advice shows that this monitoring system is working well.'
NHS England national medical director Professor Stephen Powis said: 'The MHRA have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination after two people with a history of significant allergic reactions responded adversely yesterday. Both are recovering well.'
In the US vaccine trial carried out by Pfizer, 137 out of around 19,000 people given the vaccine had one or more of these reactions. But 111 who got the placebo also had allergic reactions. Reactions to the jab can include a temperature, nausea, swelling of the arm or in severe cases feeling generally unwell with swollen lymph node glands.
A Pfizer spokesman said: 'We have been advised by MHRA of two yellow card reports that may be associated with allergic reaction due to administration of the COVID-19 BNT162b2 vaccine. As a precautionary measure, the MHRA has issued temporary guidance to the NHS while it conducts an investigation in order to fully understand each case and its causes. Pfizer and BioNTech are supporting the MHRA in the investigation.
'In the pivotal phase 3 clinical trial, this vaccine was generally well tolerated with no serious safety concerns reported by the independent Data Monitoring Committee. The trial has enrolled over 44,000 participants to date, over 42,000 of whom have received a second vaccination'.
The allergy scare came hours after Britain's drug regulator dismissed safety fears over the Pfizer/BioNTech coronavirus vaccine after a report revealed four people in a trial in the US got Bell's palsy. The condition, which is usually temporary, causes muscles on one side of the face to droop because of nerves not working properly.
Four cases of it were found in a group of 21,720 people who had the Pfizer vaccine in a trial in the US, compared to none among 21,728 people given a placebo vaccine. But this rate of occurrence is no different to how often it would be expected to happen in a random population, the company said.
Melodi
Disaster Cat
Nightwolf just brought up a real issue for Americans (for the Brits and most Europeans not so much) WHO exactly is going to pay for the hospital ER trip mandated by medical protocols for anyone that needs to use that EpiPen after an injection reaction?
Given that a simple ER Visit, perhaps with overnight observation in the USA can cost multiple thousands of dollars this is not a non-issue.
Or will Congress "deem" this to be part of the COVID-19 "Rebate" plan for hospitals - at which point I can predict with no psychic ability that every allergic reaction will be listed as "COVID related.." even if it was a bee sting or a bit of peanut butter hidden in a curry that caused it.
Given that a simple ER Visit, perhaps with overnight observation in the USA can cost multiple thousands of dollars this is not a non-issue.
Or will Congress "deem" this to be part of the COVID-19 "Rebate" plan for hospitals - at which point I can predict with no psychic ability that every allergic reaction will be listed as "COVID related.." even if it was a bee sting or a bit of peanut butter hidden in a curry that caused it.
marsh
On TB every waking moment
Four Volunteers Who Took Pfizer's COVID-19 Vaccine Developed Bell's Palsy - FDA Denies the Temporary Facial Paralysis Caused by the Shot | The Gateway Pundit | by Joe Hoft
Breaking news – Daily Mail reports that at least four individuals contracted Bell’s Palsy after taking Pfizer’s COVID-19 Vaccine. Relations between Pfizer and China also in question.
www.thegatewaypundit.com
Four Volunteers Who Took Pfizer’s COVID-19 Vaccine Developed Bell’s Palsy – FDA Denies the Temporary Facial Paralysis Caused by the Shot
By Joe Hoft
Published December 9, 2020 at 8:45am
Breaking news – Daily Mail reports that at least four individuals contracted Bell’s Palsy after taking Pfizer’s COVID-19 Vaccine. Relations between Pfizer and China also in question.
The vaccine business is big money for Big Pharma – the large corporations that benefit from the production of vaccines. This was summarized by Bobby Kennedy, Jr. months ago as he listed the protections these companies receive from the US government (similar in the manner Big Tech is protected):
UNBELIEVABLE: In New Interview Bobby Kennedy Jr. Claims Dr. Fauci will Make Millions on Coronavirus Vaccine and Owns Half the Patent | The Gateway Pundit | by Joe Hoft
Robert Kennedy Jr.
www.thegatewaypundit.com
The list of side effects from the COVID vaccine have previously been reported, but this morning Daily Mail reports that recent cases of Bells palsy developed from the Pfizer trial:
On November 13, MSM reported on the Pfizer’s progress:
What was not mentioned in the above report was that Pfizer had signed an agreement in August with Gilead.
And Gilead and Dr. Fauci were working with China in February mass producing Remdesivir:
The First Case of COVID-19 in the US Treated with Remdesivir Was in late January - Two Weeks Later China Was Mass Producing the Drug - The Firm Gilead Sciences and Dr. Fauci Are In the Middle | The Gateway Pundit | by Joe Hoft
The first known case of COVID-19 showed up in the US in Washington state on January 19, 2020. The individual had traveled to visit family in Wuhan, China, and had returned on the 15th. The patient was immediately placed under surveillance and after declining health, he was finally given a drug...
www.thegatewaypundit.com
It’s a wonder that 50% of Americans don’t want to take a COVID vaccine. This should never be mandatory.
marsh
On TB every waking moment
Zerohedge
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
www.zerohedge.com
UK Warns People With "Severe Allergies" Shouldn't Take COVID Vaccine
Wed, 12/09/2020 - 08:35
Millions of Britons, particularly the most vulnerable in their society, probably breathed a sigh of relief on Tuesday when NHS leaders introduced the first patient to receive a dose of the still-experimental Pfizer-BioNTech vaccine: A 90-year-old woman on the cusp of her 91st birthday who said she is thrilled she'll be able to spend the holiday with family without fear. Adding to the media interest, patient No. 2 was a man, 81, named "William Shakespeare".
One day later, after a week where leading vaccine developers like Pfizer and Moderna warned about supply constraints, hinting that they're widely touted projections might be unrealistic, and forcing President Trump to sign an executive order to try and ensure American patients are treated as a priority, the Britain's pharma regulator has dropped a bombshell warning.
The MHRA (Britain's regulator) warned Wednesday that any patients with histories of having "powerful allergic overreactions" should avoid the vaccine. For a report published by a professional news agency like Reuters, the details were surprisingly vague. Since a huge number of Americans are allergic to something, a little more clarity would be appreciated.
According to public opinion polls, state and federal health officials have apparently been succeeding in establishing "credibility" to these vaccines. But there's no question that setbacks like this could have a profound affect on individuals' willingness to accept the vaccine, which also reportedly comes with punishing sideeffects.
A relatively scant report released yesterday by the FDA argued the Pfizer vaccine’s efficacy and safety data met its expectations for authorization. It also warned that 0.63% of people in the vaccine group and 0.51% in the placebo group reported possible allergic reactions in trials, which Peter Openshaw, Professor of Experimental Medicine at Imperial College London, brushed off as a "very small number."
What's more: In the US, at least 2, possibly 3, participants from the Pfizer and Moderna trials have died in the following weeks.
As more serious questions arise, fueling "conspiratorial" skepticism directly challenging the narrative that the vaccines have been thoroughly and appropriately studied before being unleashed upon the population, more bold faced names are speaking up to denounce the skeptics after Joe Biden yesterday labeled wearing masks - to be fair, a totally different subject from vaccines - one's "Patriotic Duty". On CNBC earlier, author Walter Isaacson warned that choosing not to get a COVID vaccine was tantamount to endangering lives everywhere you go.
marsh
On TB every waking moment
Allergic Reactions in UK Healthcare Staff Prompt New COVID Vaccine Warnings » The National Pulse+
British health regulators have issued a warning that people with a history of “significant” allergic reactions should not receive its newly launch Pfizer/BioNTech vaccine. The warning comes in response to two National Health Service (NHS) workers who received the COVID-19 vaccine on December 8th...
thenationalpulse.com
Allergic Reactions In UK Healthcare Staff Prompt New COVID Vaccine Warnings
British health regulators have issued a warning that people with a history of “significant” allergic reactions should not receive its newly launch Pfizer/BioNTech vaccine.
The warning comes in response to two National Health Service (NHS) workers who received the COVID-19 vaccine on December 8th experiencing allergic reactions. The two individuals, who developed “anaphylactoid reaction” shortly after injection, are now recovering.
The precautions come from the Medicines and Healthcare products Regulatory Agency (MHRA) and note that anyone who has a history of “significant” allergic reactions to medicines, food, or vaccines should refuse the vaccine.
Pfizer UK responded to the development, noting the vaccine “may be associated with allergic reaction”:
“We have been advised by MHRA of two yellow card reports that may be associated with allergic reaction due to administration of the COVID-19 BNT162b2 vaccine. As a precautionary measure, the MHRA has issued temporary guidance to the NHS while it conducts an investigation in order to fully understand each case and its causes. Pfizer and BioNTech are supporting the MHRA in the investigation. In the pivotal phase 3 clinical trial, this vaccine was generally well tolerated with no serious safety concerns reported by the independent Data Monitoring Committee. The trial has enrolled over 44,000 participants to date, over 42,000 of whom have received a second vaccination.”
Melodi
Disaster Cat
And meanwhile in Alaska...
www.reuters.com
Health worker in Alaska had serious allergic reaction after Pfizer's vaccine - NYT
By Reuters Staff
1 MIN READ
(Reuters) - A health worker in Alaska had a serious allergic reaction after getting Pfizer Inc’s coronavirus vaccine, the New York Times reported on Wednesday, citing three people familiar with reports of the person’s health.
The allergic reaction occurred on Tuesday and the person was in stable condition after being hospitalized, the New York Times reported. (nyti.ms/3r2oESd)
It was not clear if the person had a history of allergic reactions, the report said.
Pfizer did not immediately respond to a request for comment.
Alaskan has allergic reaction after getting Pfizer's COVID-19 vaccine
An Alaskan health worker had a serious allergic reaction after getting Pfizer Inc and BioNTech's coronavirus vaccine, but is now stable, public health authorities said on Wednesday.
www.reuters.com
By Reuters Staff
1 MIN READ
(Reuters) - A health worker in Alaska had a serious allergic reaction after getting Pfizer Inc’s coronavirus vaccine, the New York Times reported on Wednesday, citing three people familiar with reports of the person’s health.
The allergic reaction occurred on Tuesday and the person was in stable condition after being hospitalized, the New York Times reported. (nyti.ms/3r2oESd)
It was not clear if the person had a history of allergic reactions, the report said.
Pfizer did not immediately respond to a request for comment.
And CVS, Walgreens and Walmart will have these facilities?
Melodi
Disaster Cat
This is what Nightwolf has been quietly screaming about, especially the idea of "drive-through" clinics...he said the last place you want someone having a reaction is "behind the wheel on the Freeway going 60."
The US seems determined to push this through with none of the medically indicated safeguards that some other countries are at least trying to put into place (in the UK people are supposed to be observed for at least 15 minutes after a shot).
On their part, it seems that Pfitzer never has "any comment" even to doctors, nurses, and agencies who try to get more details.
What you get instead is something along the lines of "people can react to anything," which is true, but no one has a clue what in the vaccines people are reacting to (or if they do it is a trade secret).
Meanwhile, I won't be taking this one; this kind of allergic reaction is no joke and it is why I seldom eat anything in a Chinese restaurant that isn't chicken-based, and I try to avoid eating in ones I am not familiar with.
But at least I KNOW my problem is shellfish - people getting this vaccine haven't a clue as to what the problem might be so no one with a serious allergy (for now) can take it.
Macgyver
Has No Life - Lives on TB
U.S. healthcare worker suffered allergic reaction from Pfizer vaccine
A healthcare worker in Alaska allegedly suffered a severe allergic reaction after being dosed with Pfizer's coronavirus vaccine on Tuesday and was still hospitalized as of Wednesday.
dailymail.co.uk
U.S. healthcare worker suffered allergic reaction from Pfizer vaccine
Mary Kekatos Senior
9-12 minutes
An Alaska healthcare worker suffered a serious allergic reaction within 10 minutes of receiving Pfizer Inc's coronavirus vaccine on Tuesday.
At a news conference on Wednesday, officials said the woman, who remains unarmed, started flushing and experiencing other signs of an allergic reaction after getting the jab at Bartlett Regional Hospital in Juneau.
She was hospitalized and remains stable in the ICU with expectations to be discharged later today.
The woman has no history of allergies, according to a statement from the Alaska Department of Health and Social Services.
Dr Jay Butler, the Centers for Disease Control and Prevention's (CDC) deputy director for infectious diseases, this is the only allergic reaction reported in the country thus far.
The allergic reaction is believed to be similar to the anaphylactic-like reactions suffered by two healthcare workers in Great Britain, both whom have since recovered, after they were given the Pfizer-BioNTech SE vaccine last week.
With hundreds of thousands of Americans expected to be dosed in the U.S. over the next few weeks, health officials will be on high alert to see if any other recipients experience severe reactions.
- Copy link to paste in your message
A healthcare worker in Alaska suffered a severe allergic reaction after receiving Pfizer Inc's coronavirus vaccine. Pictured: Dr. Chadi Ibrahim (right) receives the Pfizer-BioNTech COVID-19 vaccine from Susan Grand at the Beaumont Service Center in Southfield, Michigan, December 15
- Copy link to paste in your message
The worker, who is hospitalized in stable condition, has no history of drug allergies, but it is unknown if he or she suffered from other allergies. Pictured: Pfizer's vaccine
The report was first broken by The New York Times on Wednesday afternoon.
In spite of her reaction, the woman is said to be disappointed that she is unable to receive the second dose of Pfizer's vaccine.
'She kept a very positive attitude,' r Noble Anderson, a family medicine physician at Bartlett Regional Hospital, said at the news conference.
'She was excited that she got the first dose and was disappointed that she will not be getting the second dose. And she encouraged all of us to press on.'
Dr Anne Zink, Alaska's chief medical officer, said the state is not making any changes to its plan to administer the vaccine.
'There were over 40,000 people in the trials and we did not see any reactions like this,' Zink said.
According to Zink, one of the providers who treated the woman said of her reaction: 'Lightning is going to strike somewhere.'
Pfizer has said anaphylactic reactions to vaccines are rare and are estimated to occur in around one per one million doses.
'We don't yet have all the details of the report from Alaska about a potential serious allergic reactions but are actively working with local health authorities to assess,' a Pfizer spokesperson told CNN.
'We will closely monitor all reports suggestive of serious allergic reactions following vaccination and update labeling language if needed.
'The prescribing information has a clear warning/precaution that appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine.'
DailyMail.com has reached out to Pfizer for a request for comment.
PFIZER VACCINE SIDE EFFECTS
British regulators are advising that anyone who has a history of 'significant' allergic reactions to medicines, food or vaccines should not get the Pfizer coronavirus jab.
Allergic reactions to the vaccine are 'very rare', according to the trials involving more than 40,000 people.
Pfizer found a 'very small number' during its phase three clinical studies, or 137 out of 19,000 people who got the vaccine. But 111 people who were given a placebo also had allergic reactions.
They also identified 12 possible side-effects from the vaccine, with seven identified as 'very common' meaning they are likely to affect more than one in ten people. Below are the known side effects.
The patient safety leaflet for the vaccine cautions that anyone with an allergy to any of the active substances in the vaccine should not receive the jab.
Allergic reactions to the vaccine are:
Very common (Likely to affect more than one in ten people)
- Pain at injection site
- Tiredness
- Muscle pain
- Chills
- Joint pain
- Fever
- Headache
- Injection site swelling
- Redness at injection site
- Nausea
- Enlarged lymph nodes
- Feeling unwell
The immune system releases chemicals that flood the body, blood pressure suddenly drops, and airways narrow, which prevents someone from breathing normally.
Symptoms usually occur within minutes and include hives, a weak pulse, nausea, vomiting, dizziness and a swollen tongue or throat.
If not treated immediately, it can lead to death.
In the U.K., two National Health Service (NHS) staff members with a history of severe allergies suffered reactions after being immunized.
One of the workers, a 49-year-old woman, had a history of egg allergies and the other, a 40-year-old woman, had a history of drug allergies.
Both of them carried devices that contain epinephrine, a hormone that relaxes the airway muscles, in case they suffered any reactions.
A third patient also had a 'possible allergic reaction,' but British authorities neither described it nor gave an update on the patient.
Pfizer says its jab is not made with any egg ingredients.
After the reactions, the U.K.'s Medicines & Healthcare products Regulatory Agency (MHRA) issued a warning that anyone with severe allergic reactions to food or medicine not be given the vaccine.
About 32 million Americans have food allergies, according to the Asthma and Allergy Foundation of America. It's unknown how many have drug allergies.
No such warning has been issued in the U.S. as of Wednesday.
In fact, last weekend, the CDC said Americans with serious allergies can be immunized as long as they are monitored for 30 minutes after getting the shot.
However, the Food and Drug Administration (FDA) is requiring Pfizer to monitor for anaphylaxis in the U.S. and submit data, The Times reported.
The agency has also advised people with allergies to consult with their physicians to ensure they are not allergic to any components of the vaccine.
In a preliminary analysis of Pfizer's vaccine posted online last week, prior to FDA approval, a group of scientists said the jab was safe.
Among 20,000 volunteers, 137 given the shot had allergic reactions but so did 111 people who received the placebo.
This led researchers to dismiss the theory that the vaccine was a potential hazard.
Four people given the vaccine were diagnosed with Bell's Palsy, a type of facial paralysis.
However, trial scientists said there was no evidence the jab that caused the condition and that the figure was on par with the rate of Bell's Palsy in the general population.
'Among non-serious unsolicited adverse events, there was a numerical imbalance of four cases of Bell's palsy in the vaccine group compared with no cases in the placebo group, though the four cases in the vaccine group do not represent a frequency above that expected in the general population,' the analysis read.
Pfizer's vaccine began rolling out in the U.S. on Monday with 2.9 million people expected to receive the first doses.
There is currently no federal data on how many people has received the shot and most states have not revealed how many doses they have administered.
However, it is likely that tens of thousands of people across the country have been given the vaccine to date.
On Wednesday, New York Gov. Andrew Cuomo said 4,000 of the 87,750 doses received so far have been administered.
- Copy link to paste in your message
More than 80 percent of Americans over 18 said they do plan to get vaccinated - but most of those (44%, in green) plan to 'wait a bit' after the authorization of shots to get theirs
- Copy link to paste in your message
- Copy link to paste in your message
The poll, conducted by OnePoll for DailyMail.com, showed that two-thirds of men and half of women are likely to receive the jab
There are some fears that the allergic reaction will turn Americans off from getting the vaccine, which is needed to curb the spread of the pandemic.
A new poll found that nearly 84 percent of Americans say they will get a coronavirus vaccine - but most do not want to get the shot.
The survey, conducted by ABC News/Ipsos, found that 44 percent want to 'wait a bit' before being immunized.
Only two in five of the respondents said that they would get a vaccine as soon as possible.
It also found that 15 percent of Americans still say they will 'never' get a COVID-19 vaccine, with Republicans and minorities being the most reluctant.
And another survey, conducted by OnePoll for DailyMail.com, showed that just over half of Americans are willing to take the COVID-19 vaccine once it is available.
Only 67% of men and 49% of women said they were 'very' or 'somewhat' likely yo get the the vaccine.
One participant in the poll said, 'Vaccines need to be tested more than a few months before I would feel comfortable to get it. '
Another said they'd 'like to see when others take it if there are any side effects.'
Melodi
Disaster Cat
If they are not honest about the problem and upfront with it NOW, then the backlash is going to be grim.
As it is, encouraging people with severe allergic reactions to "just take this" is insane until more information is gathered; especially since these women in Alaska had no previous history of such reactions.
That isn't uncommon with severe allergies either, the only reason I have a living nephew is that the school nurse had an Epi-Pen to hand, he'd eaten peanuts all his life when suddenly at age 12, he nearly died in front of his classmates.
Now in his case, pre-COVID and CCP issues, the family spent a lot of time in China so he would learn proper Chinese (unlike his second-generation Dad who didn't) and so be able to work in any job requiring both Mandarin and English.
The theory is he got a "bad-batch" of peanut oil (probably mixed with something to extend it) that "sensitized" his body and now he can't get near peanuts at all (so probably no more trips to China even if things were normal).
As it is, encouraging people with severe allergic reactions to "just take this" is insane until more information is gathered; especially since these women in Alaska had no previous history of such reactions.
That isn't uncommon with severe allergies either, the only reason I have a living nephew is that the school nurse had an Epi-Pen to hand, he'd eaten peanuts all his life when suddenly at age 12, he nearly died in front of his classmates.
Now in his case, pre-COVID and CCP issues, the family spent a lot of time in China so he would learn proper Chinese (unlike his second-generation Dad who didn't) and so be able to work in any job requiring both Mandarin and English.
The theory is he got a "bad-batch" of peanut oil (probably mixed with something to extend it) that "sensitized" his body and now he can't get near peanuts at all (so probably no more trips to China even if things were normal).
Well gee, the needle into 10% of the Staff every other day.
Simple.
Melodi
Disaster Cat
What also needs a reminder here is that per Pfizer's own (but well hidden) trail results, a good number of people are going to get bad level 2 and level 3 reactions, which even if it doesn't put them in the hospital may keep them off the job for a week to ten days.
Dizzy people with an arm swollen twice its normal size or fevers of 104 can't work in an ICU ward, this isn't something you can "keep on carrying on with."
For many people, the symptoms are less severe, but enough people do have level 2 and 3 reactions that hospitals in the UK are already staggering their shots, usually given them at the end of a rotation before a few days break.
Dizzy people with an arm swollen twice its normal size or fevers of 104 can't work in an ICU ward, this isn't something you can "keep on carrying on with."
For many people, the symptoms are less severe, but enough people do have level 2 and 3 reactions that hospitals in the UK are already staggering their shots, usually given them at the end of a rotation before a few days break.
Hmmm... didn't I read the placebo was the meningitis vaccine? Why are they surprised?
Summerthyme
Night Owl
Veteran Member
7 COVID Vaccine Side Effects You Need to Know Before Taking It — Eat This, Not That!
The “light at the end of the tunnel” is here—a coronavirus vaccine. Chances are, the first shots will be administered as soon as next week. Requiring two doses, it only protects all Americans if enough Americans get it, so public health experts couldn’t be more clear: get yours. However, there...
apple.news
rob0126
Veteran Member
7 COVID Vaccine Side Effects You Need to Know Before Taking It — Eat This, Not That!
The “light at the end of the tunnel” is here—a coronavirus vaccine. Chances are, the first shots will be administered as soon as next week. Requiring two doses, it only protects all Americans if enough Americans get it, so public health experts couldn’t be more clear: get yours. However, there...
Quoted from the above article:
So, how many times does the 'experts' have to admit that the vaccines do not protect you, before people will believe them?
If the vaccine protected you, then why worry if somebody else has not taken it?
Why do people not see it?!
Another reaction in Alaska. No history of existing allergies.
Fair Use Cited
----------------
2 Alaska health care workers have allergic reactions after taking Pfizer's COVID-19 vaccine
BY ZOE CHRISTEN JONES
UPDATED ON: DECEMBER 17, 2020 / 9:44 AM / CBS NEWS
One health care worker in Alaska experienced a serious allergic reaction and was hospitalized after taking Pfizer's COVID-19 vaccine, state officials said Wednesday. The worker, who is middle-aged and had no previous history of allergies, had stabilized with treatment but was being kept in a Juneau hospital to be monitored for another day.
The worker received the vaccine Tuesday at Bartlett Regional Hospital. Ten minutes after taking the vaccine she "showed signs of an anaphylactic reaction, with increased heartbeat, shortness of breath and skin rash and redness," according to Dr. Lindy Jones, the emergency room director at Bartlett. "She was given epinephrine and Benadryl, admitted to the hospital, and put on an intravenous epinephrine drip. Her reaction was serious but not life threatening."
"During the whole time, she was still enthusiastic that she got the vaccine and the benefits that it would give her in the future," Jones said. The hospital's statement said she was "still encouraging her colleagues to get the vaccine."
A second health care worker, a male, suffered a less-serious allergic reaction to the vaccine at the same hospital on Wednesday. Ten minutes after getting the injection, the man experienced "eye puffiness, lightheadedness, and scratchy throat," Bartlett hospital said in a statement. "His reaction was not considered anaphylaxis."
"He felt completely back to normal within an hour and was released," after treatment in the emergency department with epinephrine, Pepcid and Benadryl, according to the hospital, which noted: "He too does not want his experience to have a negative impact on his colleagues lining up for the vaccine."
The hospital said 144 staff members were vaccinated Wednesday of a total of nearly 400 who had requested it. Data on the two allergic reactions was being shared with the CDC.
The two Bartlett workers have been the country's only cases of allergic reactions to the Pfizer vaccine, according to Dr. Jay Butler, the CDC's deputy director for infectious diseases.
The FDA authorized Pfizer's vaccine for emergency use after clinical trials showed the shot was almost 95% effective at preventing COVID-19 infection in adults between the ages of 18 and 64. None of the 44,000 participants in Phase 3 clinical trials experienced any significant adverse reactions.
Dr. Anthony Fauci, in a CNBC interview, reminded viewers that vaccine safety goes "beyond the confines" of clinical trials. "Once you decide to dispense the vaccine widely you're talking about millions and tens of millions and ultimately hundreds of millions of doses. So, you may see reactions that you didn't see in the clinical trials," he said Wednesday.
Last week, British health officials warned that people with a history of "significant" allergic reactions to vaccines, medicine, or food should not be given Pfizer's vaccine. Two health care workers there experienced "adverse reactions" after taking the drug.
"We expected that a side effect like this could occur after reports of anaphylaxis were made in England after people there received the Pfizer-BioNTech COVID-19 vaccine," Alaska's chief medical officer, Dr. Anne Zink, said in a statement Wednesday. "All sites that are approved to provide vaccinations in Alaska must have medications on hand to deal with an allergic reaction and that was the case in Juneau."
2 Alaska health care workers have allergic reactions after taking Pfizer's COVID-19 vaccine - CBS News
Fair Use Cited
----------------
2 Alaska health care workers have allergic reactions after taking Pfizer's COVID-19 vaccine
BY ZOE CHRISTEN JONES
UPDATED ON: DECEMBER 17, 2020 / 9:44 AM / CBS NEWS
One health care worker in Alaska experienced a serious allergic reaction and was hospitalized after taking Pfizer's COVID-19 vaccine, state officials said Wednesday. The worker, who is middle-aged and had no previous history of allergies, had stabilized with treatment but was being kept in a Juneau hospital to be monitored for another day.
The worker received the vaccine Tuesday at Bartlett Regional Hospital. Ten minutes after taking the vaccine she "showed signs of an anaphylactic reaction, with increased heartbeat, shortness of breath and skin rash and redness," according to Dr. Lindy Jones, the emergency room director at Bartlett. "She was given epinephrine and Benadryl, admitted to the hospital, and put on an intravenous epinephrine drip. Her reaction was serious but not life threatening."
"During the whole time, she was still enthusiastic that she got the vaccine and the benefits that it would give her in the future," Jones said. The hospital's statement said she was "still encouraging her colleagues to get the vaccine."
A second health care worker, a male, suffered a less-serious allergic reaction to the vaccine at the same hospital on Wednesday. Ten minutes after getting the injection, the man experienced "eye puffiness, lightheadedness, and scratchy throat," Bartlett hospital said in a statement. "His reaction was not considered anaphylaxis."
"He felt completely back to normal within an hour and was released," after treatment in the emergency department with epinephrine, Pepcid and Benadryl, according to the hospital, which noted: "He too does not want his experience to have a negative impact on his colleagues lining up for the vaccine."
The hospital said 144 staff members were vaccinated Wednesday of a total of nearly 400 who had requested it. Data on the two allergic reactions was being shared with the CDC.
The two Bartlett workers have been the country's only cases of allergic reactions to the Pfizer vaccine, according to Dr. Jay Butler, the CDC's deputy director for infectious diseases.
The FDA authorized Pfizer's vaccine for emergency use after clinical trials showed the shot was almost 95% effective at preventing COVID-19 infection in adults between the ages of 18 and 64. None of the 44,000 participants in Phase 3 clinical trials experienced any significant adverse reactions.
Dr. Anthony Fauci, in a CNBC interview, reminded viewers that vaccine safety goes "beyond the confines" of clinical trials. "Once you decide to dispense the vaccine widely you're talking about millions and tens of millions and ultimately hundreds of millions of doses. So, you may see reactions that you didn't see in the clinical trials," he said Wednesday.
Last week, British health officials warned that people with a history of "significant" allergic reactions to vaccines, medicine, or food should not be given Pfizer's vaccine. Two health care workers there experienced "adverse reactions" after taking the drug.
"We expected that a side effect like this could occur after reports of anaphylaxis were made in England after people there received the Pfizer-BioNTech COVID-19 vaccine," Alaska's chief medical officer, Dr. Anne Zink, said in a statement Wednesday. "All sites that are approved to provide vaccinations in Alaska must have medications on hand to deal with an allergic reaction and that was the case in Juneau."
2 Alaska health care workers have allergic reactions after taking Pfizer's COVID-19 vaccine - CBS News
heelgeneral
Senior Member
First of all, I'm guessing most here are opposed to taking the vaccine, as am I. I want no part of it, and would never take it voluntarily. On the other hand, it's very easy to sit behind a keyboard at the present time and say "I'll never take it no matter what".
What if, as many of us are concerned about, it eventually becomes mandatory to be vaccinated in order to shop at stores, have a job, etc., and have any semblance of a life in this world?
The above scenario is what I'd like to base this discussion on. My question for those smarter than me, is what can we do to protect ourselves/counteract the effects of the vaccine?
I've done my homework over the last year. I've accumulated plenty of natural remedies to take preventatively as well as in the event that myself or a family member comes down with Covid. So far, so good. Knock on wood.
What about the Vaccine? What can we do, if anything?
What if, as many of us are concerned about, it eventually becomes mandatory to be vaccinated in order to shop at stores, have a job, etc., and have any semblance of a life in this world?
The above scenario is what I'd like to base this discussion on. My question for those smarter than me, is what can we do to protect ourselves/counteract the effects of the vaccine?
I've done my homework over the last year. I've accumulated plenty of natural remedies to take preventatively as well as in the event that myself or a family member comes down with Covid. So far, so good. Knock on wood.
What about the Vaccine? What can we do, if anything?